Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-23T10:01:41.696Z Has data issue: false hasContentIssue false

Impact of Methicillin-Resistant Staphylococcus aureus Infection on Morbidity and Costs in Healthcare Facilities

Published online by Cambridge University Press:  21 June 2016

Henri A. Verbrugh*
Affiliation:
Erasmus University Medical Center, Rotterdam, The Netherlands
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2006

References

1.Cosgrove, SE, Qi, Y, Kaye, KS, et al. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005; 26:166174.Google Scholar
2.Reed, SD, Friedman, JY, Engemann, JJ, et al. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2005; 26:175183.Google Scholar
3.Vos, MC, Verbrugh, HA. MRSA: we can overcome, but who will lead the battle? Infect Control Hosp Epidemiol 2005; 26:117120.Google Scholar
4.Haley, RW, Schaberg, DR, Von Allmen, SD, McGowan, JE Jr. Estimating the extra charges and prolongation of hospitalization due to nosocomial infections: a comparison of methods. J Infect Dis 1980; 141:248257.Google Scholar
5.Kim, T, Oh, PI, Simor, AE. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infect Control Hosp Epidemiol 2001; 22:99104.CrossRefGoogle Scholar